Helsinn promotes the use of mobile technology in cancer supportive care through mobile health 10 April 2014
Helsinn and Chugai Pharma Marketing enter into agreement for rights of Anamorelin, currently in development for treatment of anorexia-cachexia syndrome related to non-small cell lung cancer in top EU markets 12 November 2013
10 young students from the Sopraceneri area receive Helsinn Advanced Synthesis SA 2013/2014 educational scholarships 9 October 2013
Linkedin